Danilo Malandrino

Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together?

A. Berni, Danilo Malandrino, Giancarlo Parenti et al. · Journal of Endocrinological Investigation · 2020 · 144 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +8

Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study

Alessandra Vultaggio, Emanuele Vivarelli, Gianni Virgili et al. · The Journal of Allergy and Clinical Immunology In Practice · 2020 · 80 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +16

Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study

Alessandro M. Vannucchi, Benedetta Sordi, A Morettini et al. · Leukemia · 2020 · 76 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Serum sodium alterations in SARS CoV-2 (COVID-19) infection: impact on patient outcome

Andrea Berni, Danilo Malandrino, Giovanni Corona et al. · European Journal of Endocrinology · 2021 · 52 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +17

Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort

Elisabetta Zanatta, Elisabetta Cocconcelli, G. Castelli et al. · RMD Open · 2023 · 41 citations · Full text

Medicine, Internal Medicine, Radiology +17